Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes - Radioactive and Nonradioactive

Long lived radionuclidic impurities in FASTlab F-18 FDG citrate

Daniel Yokell, Philip DeNoble, Stephen Dragotakes, David Lee, Ronald Moore, Peter Rice and John Correia
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1197;
Daniel Yokell
1Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip DeNoble
1Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Dragotakes
1Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Lee
1Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronald Moore
1Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Rice
1Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Correia
1Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1197

Objectives Previously published long lived radionuclidic impurity analyses were from silver targets with havar foils at low current and using older FDG synthesis modules. The authors believe this to be the first report of long lived radionulcidic impurities on the FASTlab FDG synthesis unit using high yield F-18 niobium targets with havar foils.

Methods A total of 3 FDG lots produced using the FASTlab FDG citrate cassette were analyzed after a 14 day decay period. Approximately 12Ci of F-18 fluoride was produced by dual target bombardment of >97% H218O at 50µA per target for 3 hrs. Standard FDG syntheses were conducted and all specifications were met for clinical use. At 14 days, a 1mL aliquot of the FDG was counted on a high purity germanium spectrometer for 2 hours. Non-background photopeaks in the spectra were identified, integrated and converted to absolute radioactivity units. The measured activities were corrected to FDG lot expiration, 12 hours post end of synthesis.

Results The following radionuclides were detected in each lot: Co-56, Co-57, Co-58, Cr-51, Mn-54, Tc-95m, Re-183 and Re-184. The largest average radionuclidic impurity was Re-183 (187nCi), with the average sum of radionuclidic impurities of 348nCi per lot, an average of 0.041% contaminant level at lot expiration.

Conclusions The work presented here shows a higher detected level of long-lived radionuclidic impurities in the FDG formulation than previously reported. Some shorter lived impurities may have been missed due to the 14 day decay. The reported level is well below NRC and USP regulatory limits for long lived radionuclidic impurities. The higher level of impurities is postulated to originate from the elution of QMA SPE, as the FASTlab, unlike previously reported systems, elutes the QMA using a flow in the opposite direction from F18 loading. This would allow impurities trapped at the top of the QMA to be carried into the FDG synthesis. The long lived radionuclidic impurities are consistent with being produced in the havar foils during bombardment.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 54, Issue supplement 2
May 2013
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Long lived radionuclidic impurities in FASTlab F-18 FDG citrate
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Long lived radionuclidic impurities in FASTlab F-18 FDG citrate
Daniel Yokell, Philip DeNoble, Stephen Dragotakes, David Lee, Ronald Moore, Peter Rice, John Correia
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1197;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Long lived radionuclidic impurities in FASTlab F-18 FDG citrate
Daniel Yokell, Philip DeNoble, Stephen Dragotakes, David Lee, Ronald Moore, Peter Rice, John Correia
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1197;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes - Radioactive and Nonradioactive

  • Synthesis and evaluation of radiolabeled oleanolic acid for diagnosis of colon cancer using PET
  • Radioiodinated BMIPP as a potential probe for hepatic fatty acid metabolism: Evaluation in mice at different feeding status
  • Monitoring bevacizumab therapy with PET/CT and 68Ga-NODAGA-c(RGDfK)
Show more Molecular Targeting Probes - Radioactive and Nonradioactive

Special MTA: Radiopharmacy Posters

  • Improved synthesis and purification of C-11 PBR-28
  • Preclinical and a first-in man studies on [11C]CB184 for imaging 18 kDa translocator protein by positron emission tomography
  • Synthesis of [18F]Tetrafluoroborate ([18F]TFB) via Radiofluorination of Boron Trifluoride and Evaluation in a Murine C6-Glioma Tumor Model
Show more Special MTA: Radiopharmacy Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire